Immune Response to Hepatitis B Vaccine in HIV-Infected Subjects Using Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as a Vaccine Adjuvant: ACTG Study 5220

HIV-infected persons are at risk for HBV co-infection which is associated with increased morbidity and mortality. Unfortunately, protective immunity following HBV vaccination in HIV-infected persons is poor. This randomized, phase II, open label study aimed to evaluate efficacy and safety of 40 mcg...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Overton, ET, Kang, M, Peters, MG, Umbleja, T, Alston-Smith, BL, Bastow, B, Demarco-Shaw, D, Koziel, MJ, Mong-Kryspin, L, Sprenger, HL, Yu, JY, Aberg, JA
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2943846/
https://ncbi.nlm.nih.gov/pubmed/20600512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2010.06.030
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky